Taipei, Taiwan

Cherng-Jyh Ke

This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cherng-Jyh Ke. Retrieved from https://idiyas.com/inventor/cherng-jyh-ke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cherng-Jyh Ke: Innovator in Stem Cell Research

Introduction

Cherng-Jyh Ke is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells. His innovative work has the potential to advance medical treatments and regenerative therapies.

Latest Patents

Cherng-Jyh Ke holds a patent for a "Kit and method for promoting mesenchymal stem cell differentiation." This invention includes a kit comprising a mesenchymal stem cell, a gelatin-hyaluronan-chondroitin tri-copolymer scaffold, a kartogenin, and a bioreactor. The method described in the patent promotes the differentiation of mesenchymal stem cells into cartilage tissue through specific culturing techniques.

Career Highlights

Cherng-Jyh Ke is affiliated with National Taiwan University, where he conducts research and develops innovative solutions in the field of stem cell biology. His work has garnered attention for its potential applications in regenerative medicine.

Collaborations

Cherng-Jyh Ke collaborates with notable colleagues, including Feng-Huei Lin and Jui-Sheng Sun, to further advance research in stem cell differentiation and related fields.

Conclusion

Cherng-Jyh Ke's contributions to stem cell research exemplify the impact of innovation in medical science. His patented methods and collaborative efforts continue to pave the way for advancements in regenerative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…